4th Quarter - Report

TARPLIN STRATEGIES LLC for GENENTECH, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Government reimbursement for biotherapeutics.

LobbyistCovered position, as disclosed
RICHARD JOSEPH TARPLIN and Families

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

General health care reform issues. Government reimbursement for biotherapeutics. Comparative effectiveness research. Legislative and regulatory issues involved in FDA approval of follow-on biologics.

LobbyistCovered position, as disclosed
RICHARD JOSEPH TARPLIN and Families

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Legislative and regulatory issues involved in FDA approval of follow-on biologics.

LobbyistCovered position, as disclosed
RICHARD JOSEPH TARPLIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medical/Disease Research/Clinical Labs MED

Comparative effectiveness research.

LobbyistCovered position, as disclosed
RICHARD JOSEPH TARPLIN and Families

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.